Tech
AI in Drug Development and US-China AI Tensions
Artificial intelligence is accelerating drug development, with a proprietary survey indicating potential for greater automation. Meanwhile, the Trump administration considers banning Chinese AI models to maintain dominance over OpenAI and Anthropic.
Coverage timeline — 2 articles
Axios
The Trump administration is showing signs it could ban cutting-edge Chinese AI models — a momentous move that could lock in dominance by OpenAI and Anthropic.Why it matters: </
2026-07-20 09:30 UTC
Axios
Artificial intelligence is dramatically speeding up drug development — and a proprietary survey shows how it's priming a bigger automation push that's changing the trajectory of early stag
2026-07-20 09:30 UTC